Immuno Oncology Assays Market Overview 2019 – Size, Share, Global Analysis with Fervent Players, Segments, Top Trends, Type, Applications, Methods and Forecast to 2027

Immuno-oncology assays focus on development of precision cancer treatments, using new techniques and technologies that employ body’s natural defenses to target and eliminate cancer cells. The approach is a next generation sequencing application that aids in retaining cell morphology and health for real time measurements or continuous analysis. Assays such as T cell assays, tumor-eliminating assays, tumor cell assays, natural killer cell assays, macrophage assays, and dendritic cell assays are some of the types of immuno-oncology assays.

Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-sample/2632

Increasing approval and launch of products to augment growth of the market

Key players in the market are focused on approval and launch of new products to expand their product portfolio, which is expected to boost growth of the global immuno-oncology market during the forecast period. For instance, in April 2019, Roche Diagnostics launched the new VENTANA HER2 Dual ISH DNA Probe Cocktail assay for identification of human epidermal growth factor receptor 2 (HER2) biomarker in breast and gastric cancers. In August 2018, Thermo Fisher Scientific announced that it has validated Thermo Oncomine Tumor Mutation Load Assay for clinical trials which is a latest approach in the immuno-oncology treatment. Therefore, it is expected to become a rapid and independent predictor for patient’s satisfaction and response to cancer treatment.

Difficulties in production of immuno-oncology assays to hamper the market growth

There are several challenges in production of immuno-oncology assays and it requires specialist teams and experienced investigators. The production of immuno-oncology assays is also associated with high cost and time required for production. Such factors are expected to hamper growth of the market over the forecast period.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CHRISTMAS2020” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2632

North America immuno-oncology assays market to account for the largest market share

The market in North America is expected to account for the largest market share over the forecast period. Key players in the market are focused on adopting collaboration strategies to expand their product portfolio, thereby aiding in growth of the market. For instance, in May 2018, Five Prime Therapeutics collaborated with Roche Diagnostics for the development and validation of CDx assay (a companion diagnostic assay).

The market in Asia Pacific is expected to witness significant growth in the global immuno-oncology assays market over the forecast period. This is attributed to focus of key players in the market on approval and launch of new immuno-oncology assays. For instance, in April 2018, BellBrook Labs (based in China) launched new Transcreener cGAS Activity Assays designed specifically for the treatment of cancer and autoimmune disorders.

To get detailed table of content (ToC), please click – https://www.coherentmarketinsights.com/ongoing-insight/toc/2632

Key players operating in the immuno oncology market include Roche Diagnostics, Sartorius AG, Agilent Technologies, HTG Molecular Diagnostics, Qiagen, Merck, Thermo Fischer Scientific, lllumina, Merck, and Perkinelmer.

Immuno Oncology Assay Market –Taxonomy

On the basis of product type, the global immuno-oncology assays market is segmented into:

• Consumables
• Software

On the basis of technology, the global immuno-oncology assays market is segmented into:

• Next Generation sequencing
• Flow Cytometry
• PCR
• Others

On the basis of indication, the global immuno-oncology assays market is segmented into:

• Lung cancer
• Colorectal cancer
• Melanoma
• Leukemia
• Lymphoma
• Multiple myeloma
• Bladder cancer
• Others

On the basis of region the, global immuno-oncology assays market segmented into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.